Drug details
Abrilada (adalimumab-afzb injection, for subcutaneous use)
type of DMARDs, TNF Inhibitors, Monoclonal Antibodies
Abrilada (adalimumab-afzb) is a tumor necrosis factor (TNF) blocker used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn's disease, ulcerative colitis and plaque psoriasis. Abrilada is biosimilar to Humira (adalimumab).
The drug is often used to treat Ankylosing spondylitis , Arthritis , Psoriatic arthritis , Ulcerative colitis .
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- loss of appetite,
- dark urine,
- vomiting,
- fever,
- swollen glands,
- night sweats,
- general feeling of illness,
- joint and muscle pain,
- skin rash,
- easy bruising,
- unusual bleeding,
- pale skin,
- lightheadedness,
- shortness of breath,
- cold hands and feet,
- pain in your upper stomach that may spread to your shoulder,
- feeling full after eating only a small amount,
- weight loss,
- new or worsening psoriasis (raised, silvery flaking of the skin),
- sore or bump on your skin that does not heal,
- confusion,
- chills,
- severe drowsiness,
- fast heartbeats,
- rapid breathing,
- body aches,
- tiredness,
- stomach pain,
- right sided upper stomach pain,
- clay-colored stools,
- yellowing of the skin or eyes (jaundice),
- joint pain or swelling,
- chest pain,
- patchy skin color that worsens in sunlight,
- numbness,
- tingling,
- dizziness,
- vision problems,
- weakness in your arms or legs, and
- fever with ongoing cough
The following drugs are related to Abrilada, either as a replacement or used together:
- Orencia (abatacept)
- Actemra (tocilizumab injection)
- Humira (adalimumab injection solution for subcutaneous administration)
- Imraldi (adalimumab-xxxx injection, for subcutaneous use)
- Cimzia (certolizumab pegol injection)
- Enbrel (etanercept)
- Simponi Aria (golimumab for infusion)
- Simponi Injection (golimumab injection)
- Plaquenil (hydroxychloroquine)
- Remicade (infliximab)
- Trexall (methotrexate)
- Rinvoq (upadacitinib extended-release tablets)
- Rituxan (rituximab)
- Rituxan Hycela (rituximab and hyaluronidase human injection)
- Xeljanz (tofacitinib tablets)